Announcements Trials
Browse Landscape

Phase

Phase 1 6

Status

Completed 7Recruiting 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 31Gastrointestinal 14Tumor-Agnostic 7Thoracic 6Other solid neoplasm 5Head & Neck 5CNS 4Sarcoma 3Endocrine 3Dermatologic 3Gynecologic 2Breast 2Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1

Conditions

Neoplasms 5Carcinoma 3

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Axitinib × Tumor-Agnostic × Clear all
NCT04033991 2023-04-06

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Pfizer

Completed
684 enrolled 20 charts
Tumor-Agnostic

Carcinoma, Neoplasms

NCT01999972 2020-09-24

A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Completed
50 enrolled 29 charts
Tumor-Agnostic

Carcinoma

NCT00859118 2019-11-19

Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies

University of Wisconsin, Madison

Phase 1 Completed
30 enrolled
Tumor-Agnostic

Neoplasms

NCT01529138 2015-04-13

Study of Axitinib and Temsirolimus in Solid Tumors

Emory University

Phase 1 Completed
13 enrolled
Tumor-Agnostic

Neoplasms

NCT00447005 2012-05-23

Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Completed
12 enrolled 16 charts
Tumor-Agnostic

Carcinoma

NCT00726752 2012-05-23

A Study In Patients With Advanced Solid Tumor

Pfizer

Phase 1 Completed
6 enrolled 16 charts
Tumor-Agnostic

Neoplasms

NCT00454649 2012-04-04

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Pfizer

Phase 1 Completed
102 enrolled 48 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡